Our strategy sets out to bring deeper mechanistic understanding at the molecular and cellular level to all stages of projects, from Idea to pre-clinical candidate.
In this role, you will define the vision and strategy for CRH early project enablement, establishing robust processes to select and advance promising targets into the drug discovery portfolio. You will lead and develop a matrixed team, guiding them to deliver clear go/nogo decisions through deep expertise in target feasibility and druggability.
You will work closely with the Portfolio Generation team to build a sustainable pipeline, evaluating risks, shaping mitigation strategies, and ensuring projects progress efficiently toward clinical development. In addition, you will provide leadership within the broader CRH TI organisation, shaping strategic direction and driving scientific and technical innovation, including championing new modalities.